|
Friday, November 22, 2019
Print Current Session:
 |
|
|
Friday
SESSION 76:
UPDATES ON THE COMPLETED AND ONGOING CAROTID RCTs AND THEIR PITFALLS; NEED FOR POST CEA/CAS SURVEILLANCE; IMPLICATIONS OF FILTER DEBRIS
|
|
| SESSION 76 SCHEDULE | |
| 2:07 PM - 2:12 PM | Pooled Analysis Of ACT 1 And CREST In Asymptomatic Carotid Stenosis (ACS) Patients Under 80 Years Of Age: How It Can Help In Decision Making |
|
Presenter(s):Jon S. Matsumura, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:13 PM - 2:18 PM | Stroke And TIA Rates After 1 Year In SPACE 2: A Stopped RCT Comparing CEA Versus CAS Versus Best Medical Treatment In ACS Patients: What Hint Do They Give Us |
|
Presenter(s):Hans-Henning Eckstein, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:19 PM - 2:24 PM | DEBATE: Update On Progress In CREST 2: It Will Produce Valuable Results, Conclusions And Answers: Interesting Findings To Date |
|
Presenter(s):Brajesh K. Lal, MD / Thomas G. Brott, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:25 PM - 2:30 PM | DEBATE: Not So: A Skeptic’s View: Why CREST 2, A Good RCT, May Produce Interesting Information But Will Not Answer Key Questions Or Settle Existing Controversy |
|
Presenter(s):Anne L. Abbott, MD, PhD, FRACP Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:31 PM - 2:36 PM | What Impact Will CREST 2 Have On CEA And CAS And The Controversy Surrounding The Treatment Of Patients With ACS: Predictions For The Future Of Carotid Treatment - Invasive And Otherwise |
|
Presenter(s):L. Nelson Hopkins, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:37 PM - 2:42 PM | Current Status Of ECST 2: What Is This RCT Comparing: What Will It Tell Us And What Is Its Progress |
|
Presenter(s):Richard Bulbulia, MA MD FRCS Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:43 PM - 2:48 PM | Update On ACST 2: When Will This RCT Complete Recruitment: What Has It Told Us Thus Far: What Are Its Limitations |
|
Presenter(s):Alison Halliday, MS, FRCS Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:49 PM - 2:54 PM | Pitfalls And Limitations Of The Esteemed And Often Quoted CAS Versus CEA RCTs: Why They May Be Misleading |
|
Presenter(s):Ali F. AbuRahma, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:55 PM - 3:00 PM | Addition To CEA Of A Proximal Intervention (To Common Carotid Or Innominate Arteries) Increases The Risk Of Stroke Or Death: From SVS VQI Data |
|
Presenter(s):Mark Conrad, MD, MMSc Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 3:01 PM - 3:06 PM | Qualitative Analysis Of Embolic Debris Caught In Different Filters During CAS: What Is Their Nature And What Are The Implications |
|
Presenter(s):Franco Grego, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 3:07 PM - 3:14 PM | Panel Discussion |
| 3:14 PM - 3:24 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 76 | |
| previous | next |